IN2014MN00937A - - Google Patents
Info
- Publication number
- IN2014MN00937A IN2014MN00937A IN937MUN2014A IN2014MN00937A IN 2014MN00937 A IN2014MN00937 A IN 2014MN00937A IN 937MUN2014 A IN937MUN2014 A IN 937MUN2014A IN 2014MN00937 A IN2014MN00937 A IN 2014MN00937A
- Authority
- IN
- India
- Prior art keywords
- carrier
- free radicals
- damage caused
- drug
- antioxidant
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
- A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/34—Copper; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
- A61K38/063—Glutathione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/CN2012/085066 WO2014079020A1 (en) | 2012-11-22 | 2012-11-22 | Pharmaceutical composition used for reducing damage caused by free radicals |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2014MN00937A true IN2014MN00937A (zh) | 2015-09-04 |
Family
ID=50775402
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN937MUN2014 IN2014MN00937A (zh) | 2012-11-22 | 2012-11-22 |
Country Status (11)
Country | Link |
---|---|
US (1) | US9700623B2 (zh) |
EP (1) | EP2922573B1 (zh) |
JP (1) | JP5920955B2 (zh) |
KR (1) | KR101730057B1 (zh) |
CN (1) | CN104114188A (zh) |
AU (1) | AU2012394378B2 (zh) |
BR (1) | BR112014013185A2 (zh) |
CA (1) | CA2851130C (zh) |
IL (1) | IL232938B (zh) |
IN (1) | IN2014MN00937A (zh) |
WO (1) | WO2014079020A1 (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102329495B1 (ko) * | 2015-02-23 | 2021-11-24 | 주식회사 파마리서치 | 소듐 2-메르캅토에탄 설포네이트를 삼투압 조절제로서 함유하는 생체투여 또는 미용성형용 생분해성 고분자 조성물 |
KR102336699B1 (ko) * | 2015-02-23 | 2021-12-08 | 주식회사 파마리서치 | 소듐 2-메르캅토에탄 설포네이트를 함유하는 히알루론산의 분해억제제 및 이를 포함하는 조성물 |
CN106267223A (zh) * | 2015-05-11 | 2017-01-04 | 华东理工大学 | 一种基于氧自由基的靶向功能材料及其应用 |
CN110200941B (zh) * | 2019-06-24 | 2020-05-15 | 苏州大学 | 作用于小肠的辐射防护纳米药物及其制备方法 |
CN115516077A (zh) * | 2020-06-22 | 2022-12-23 | 凸版印刷株式会社 | 凝胶组合物及其制造方法以及三维组织体及其制造方法 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH03184922A (ja) * | 1989-12-14 | 1991-08-12 | Pola Chem Ind Inc | 皮膚外用剤 |
JPWO2006033412A1 (ja) * | 2004-09-24 | 2008-05-15 | 株式会社林原生物化学研究所 | 放射線障害軽減剤 |
US8758723B2 (en) * | 2006-04-19 | 2014-06-24 | The Board Of Regents Of The University Of Texas System | Compositions and methods for cellular imaging and therapy |
KR100752990B1 (ko) * | 2006-08-02 | 2007-08-30 | 주식회사 대웅 | 나노리포좀 및 천연 추출물을 포함하는 피부 질환의 예방또는 치료용 조성물 |
US20120197060A1 (en) * | 2009-06-18 | 2012-08-02 | University Of Utah Research Foundation | Radiation enhanced macromolecular delivery of therapeutic agents for chemotherapy technology |
GB0911002D0 (en) * | 2009-06-25 | 2009-08-12 | Univ Leuven Kath | Metal organic framework synthesis |
CN102821605B (zh) * | 2010-03-26 | 2015-11-25 | 安哥洛华治疗公司 | 改进的稳定的(e)-4-羧基苯乙烯基-4-氯苄基砜水性制剂 |
WO2012058552A1 (en) * | 2010-10-29 | 2012-05-03 | Intezyne Technologies, Incorporated | Iron stabilized polymer micelles for drug delivery applications |
US20130071482A1 (en) * | 2011-09-20 | 2013-03-21 | The University Of Kentucky Research Foundation | Block copolymer cross-linked nanoassemblies as modular delivery vehicles |
TWI568453B (zh) * | 2011-11-22 | 2017-02-01 | 原創生醫股份有限公司 | 具有螯合型複合微胞之藥物載體及其應用 |
US8785569B2 (en) * | 2011-11-22 | 2014-07-22 | Original Biomedicals Co., Ltd. | Drug carrier with chelating complex micelles and the application thereof |
-
2012
- 2012-11-22 WO PCT/CN2012/085066 patent/WO2014079020A1/en active Application Filing
- 2012-11-22 AU AU2012394378A patent/AU2012394378B2/en not_active Ceased
- 2012-11-22 JP JP2014555061A patent/JP5920955B2/ja active Active
- 2012-11-22 CN CN201280054773.7A patent/CN104114188A/zh active Pending
- 2012-11-22 IN IN937MUN2014 patent/IN2014MN00937A/en unknown
- 2012-11-22 US US14/348,100 patent/US9700623B2/en active Active
- 2012-11-22 CA CA2851130A patent/CA2851130C/en active Active
- 2012-11-22 BR BR112014013185A patent/BR112014013185A2/pt not_active IP Right Cessation
- 2012-11-22 KR KR1020147009360A patent/KR101730057B1/ko active IP Right Grant
- 2012-11-22 EP EP12885938.6A patent/EP2922573B1/en active Active
-
2014
- 2014-06-02 IL IL232938A patent/IL232938B/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
AU2012394378A1 (en) | 2014-06-12 |
CN104114188A (zh) | 2014-10-22 |
US20150290321A1 (en) | 2015-10-15 |
IL232938B (en) | 2018-04-30 |
US9700623B2 (en) | 2017-07-11 |
JP2015510503A (ja) | 2015-04-09 |
KR20140097122A (ko) | 2014-08-06 |
EP2922573B1 (en) | 2018-11-14 |
CA2851130C (en) | 2019-10-01 |
CA2851130A1 (en) | 2014-05-22 |
JP5920955B2 (ja) | 2016-05-24 |
WO2014079020A1 (en) | 2014-05-30 |
KR101730057B1 (ko) | 2017-04-25 |
AU2012394378B2 (en) | 2016-06-02 |
BR112014013185A2 (pt) | 2017-06-13 |
IL232938A0 (en) | 2014-07-31 |
EP2922573A4 (en) | 2016-07-20 |
EP2922573A1 (en) | 2015-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12020500352A1 (en) | Therapeutic uses of empagliflozin | |
PH12016501015A1 (en) | Combinations of histone deacetylase inhibitors and immunomodulatory drugs | |
BR112015011830A2 (pt) | compostos e seus métodos de utilização | |
PH12016500871A1 (en) | Combination therapy including an mdm2 inhibitor and one or more additional pharmaceutically active agents for the treatment of cancers | |
MX2020003174A (es) | Terapia de combinacion que comprende un inhibidor de tor cinasa y un compuesto imid para tratar cancer. | |
EP3031826A4 (en) | Pharmaceutical composition for treatment and/or prevention of cancer | |
MX2015005963A (es) | Inhibidores heterociclicos de glutaminasa. | |
MX2015013948A (es) | Composicion farmaceutica, metodos para tratamiento y sus usos. | |
IN2014MN00937A (zh) | ||
IN2014DN10670A (zh) | ||
CL2015000897A1 (es) | Composición farmacéutica que contiene un portador de oxígeno basado en hemoglobina para el tratamiento de focalización de cáncer y prevención de recurrencia de cáncer. | |
BR112015026238A2 (pt) | tratamento de câncer com dihidropirazino-pirazinas | |
PH12014501140A1 (en) | Protective agent for keratoconjunctiva or suppressive agent for keratoconjunctival disorder | |
TN2015000255A1 (fr) | Chitine ou ses derives pour la prevention et/ou le traitement de parasitoses | |
MX2015000485A (es) | Tratamiento de esclerosis multiple con una combinacion de laquinimod y fampridina. | |
MX2016001536A (es) | Derivados de urea de piperidinas. | |
WO2014182789A3 (en) | Radiomitigating pharmaceutical formulations | |
EP2962693A4 (en) | PHARMACEUTICAL COMPOSITION FOR THE PREVENTION AND / OR TREATMENT OF CANCER | |
EA201201483A1 (ru) | Способы и композиции для защиты от нейротоксических веществ | |
EA201690874A1 (ru) | Препятствующие злоупотреблению гранулированные лекарственные формы с немедленным высвобождением | |
MX2016004909A (es) | Composicion que contiene eugenol como principio activo para prevenir o tratar la dermatitis atopica. | |
MX2015013755A (es) | Formulacion farmaceutica para uso en el tratamiento y/o prevencion de restenosis. | |
MX363378B (es) | Composiciones nanoparticuladas y formulaciones de compuestos de piperazina. | |
WO2013157889A9 (ko) | 신규한 아미노피리딘 유도체의 암 예방 또는 치료 용도 | |
PL405129A1 (pl) | Nowe peptydomimetyki o aktywności antyangiogennej |